Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Pros & Cons of Combining Different Specialties Under One Roof

Gregory C. Gardner, MD, FACP  |  Issue: July 2018  |  July 19, 2018


Gregory C. Gardner, MD, FACPGregory C. Gardner, MD, FACP, is the Gilliland-Henderson Professor of Medicine in the Division of Rheumatology at the University of Washington, and an adjunct professor of orthopedics and rehabilitation medicine at the University of Washington.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

3 Physicians from the Author’s Combined Clinics Chime In

Lawrence Ho, MD, an ILD-trained pulmonologist in a combined ILD/rheumatology clinic:

“The combined rheumatology/ILD clinic is a huge benefit to both providers and patients. These visits allow for a true multidisciplinary approach as the rheumatologist and pulmonologist discuss the patient’s case either in front of the patient or immediately before or after the clinic visit. This communication is vital for our patients because they all present with complex disease, and often communication is lacking when patients are seen at different clinics or institutions. Not only are these clinics a great convenience for the patients because many travel from a distance and have busy work/life schedules, but the multidisciplinary approach instills trust and confidence in the medical team and the care provided.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Judy Juo, MD, a third-year rheumatology fellow:

“I enjoy working in a combined clinic very much. In a combined clinic, we have the benefit of direct communication between subspecialists, which not only saves us time but also allows us to provide better patient care by coming up with a consistent treatment plan. It also saves the patients time because they do not have to go through the hassle of traffic, finding parking spaces, etc., more than once. Last but not least, I simply enjoy learning from and working with other subspecialists that I would have never met in person otherwise in a huge system like the University of Washington.”

Andrea Kalus, MD, a medicine-trained dermatologist and dermatology attending:

“Working in a combined setting provides a renewed joy of practice. Being able to observe elements of medical practice outside my own specialty rekindles the curiosity that drives so many of us to medicine to begin with. Good listening skills, responsive communication and, at times, challenging each other intellectually make sure things don’t fall through the cracks. Whenever possible I try to make time to attend the other specialties’ grand rounds or regional meetings because it helps deepen my understanding of the clinical content and also forges my relationship with a new community of providers. Referring providers appreciate the combined approach because it avoids treatment plans that have discrepancies. It is experienced almost universally positively by patients, even when they have to wait extra time. It works best as a referral service that provides guidance in diagnosis and treatment. For specialties like dermatology, it may come at the cost of productivity. Despite that, it is a highly desired service for referrals.”

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:FacilityPractice SupportWorkforce Tagged with:specialty

Related Articles

    What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)

    December 1, 2012

    Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
     

    Scleroderma & ILD: Practical Tips on the Diagnosis & Management of Systemic Sclerosis-Associated Interstitial Lung Disease

    June 15, 2022

    No one-size-fits-all approach exists for the care and treatment of patients with systemic sclerosis (SSc) and SSc with pulmonary involvement. Here, experts discuss some best clinical practices for these patients.

    Tocilizumab Effective for Early SSc-Associated Interstitial Lung Disease

    September 22, 2021

    Treatment with tocilizimab preserved lung function in patients with systemic sclerosis (SSc) and interstitial lung disease (ILD) regardless of a patient’s level of lung involvement, according to a recent study.

    New Africa / shutterstock.com

    A Rheumatologist & Pulmonologist Discuss RA-ILD

    November 14, 2021

    Introduction The understanding and treatment of rheuma­toid arthritis (RA) has evolved dramatically in the past 20 years. As gains have been made in treating joint disease in RA, our understanding of the impact of extra-articular manifestations of RA, such as cardiac and lung disease—specifically interstitial lung disease (ILD)—has gradually increased. While rheumatologists increasingly appreciate the…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences